Bright Minds Biosciences (DRUG) Share-based Compensation (IS): 2020-2021
Historic Share-based Compensation (IS) for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to $299,147.
- Bright Minds Biosciences' Share-based Compensation (IS) was N/A to $299,147 in Q3 2021 from the same period last year, while for Sep 2021 it was $700,787, marking a year-over-year change of. This contributed to the annual value of $696,772 for FY2021, which is 480.63% up from last year.
- According to the latest figures from Q3 2021, Bright Minds Biosciences' Share-based Compensation (IS) is $299,147, which was up 41.00% from $212,165 recorded in Q2 2021.
- In the past 5 years, Bright Minds Biosciences' Share-based Compensation (IS) ranged from a high of $299,147 in Q3 2021 and a low of $90,522 during Q4 2020.
- For the 2-year period, Bright Minds Biosciences' Share-based Compensation (IS) averaged around $175,197, with its median value being $155,559 (2021).